265 related articles for article (PubMed ID: 32079861)
1. Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.
Vijayaraghavan R; Jindal A; Arora V; Choudhary A; Kumar G; Sarin SK
Am J Gastroenterol; 2020 May; 115(5):729-737. PubMed ID: 32079861
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic prevention of variceal bleeding and rebleeding.
Baiges A; Hernández-Gea V; Bosch J
Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
[TBL] [Abstract][Full Text] [Related]
4. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
[TBL] [Abstract][Full Text] [Related]
5. Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.
Abraldes JG; Villanueva C; Aracil C; Turnes J; Hernandez-Guerra M; Genesca J; Rodriguez M; Castellote J; García-Pagán JC; Torres F; Calleja JL; Albillos A; Bosch J;
Gastroenterology; 2016 May; 150(5):1160-1170.e3. PubMed ID: 26774179
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic response to primary prophylactic therapy with nonselective β-blockers is related to a reduction of first variceal bleeding risk in liver cirrhosis: a meta-analysis.
Kerbert AJ; Chiang FW; van der Werf M; Stijnen T; Slingerland H; Verspaget HW; van Hoek B; Coenraad MJ
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):380-387. PubMed ID: 28002118
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial.
Shah HA; Azam Z; Rauf J; Abid S; Hamid S; Jafri W; Khalid A; Ismail FW; Parkash O; Subhan A; Munir SM
J Hepatol; 2014 Apr; 60(4):757-64. PubMed ID: 24291366
[TBL] [Abstract][Full Text] [Related]
8. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.
Zacharias AP; Jeyaraj R; Hobolth L; Bendtsen F; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011510. PubMed ID: 30372514
[TBL] [Abstract][Full Text] [Related]
9. Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding Rates Than Propranolol in Secondary Prophylaxis.
Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Balcar L; Hofer B; Pfisterer N; Schwarz M; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T
Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2318-2326.e7. PubMed ID: 35842118
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study.
Schwarzer R; Kivaranovic D; Paternostro R; Mandorfer M; Reiberger T; Trauner M; Peck-Radosavljevic M; Ferlitsch A
Aliment Pharmacol Ther; 2018 Apr; 47(8):1162-1169. PubMed ID: 29492989
[TBL] [Abstract][Full Text] [Related]
11. A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis.
Kim SG; Kim TY; Sohn JH; Um SH; Seo YS; Baik SK; Kim MY; Jang JY; Jeong SW; Lee B; Kim YS; Suk KT; Kim DJ
Am J Gastroenterol; 2016 Nov; 111(11):1582-1590. PubMed ID: 27575713
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCT.
Gupta V; Rawat R; Shalimar ; Saraya A
Hepatol Int; 2017 Mar; 11(2):181-187. PubMed ID: 27624505
[TBL] [Abstract][Full Text] [Related]
13. Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial.
Pollo-Flores P; Soldan M; Santos UC; Kunz DG; Mattos DE; da Silva AC; Marchiori RC; Rezende GF
Dig Liver Dis; 2015 Nov; 47(11):957-63. PubMed ID: 26321186
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial.
Mishra SR; Chander Sharma B; Kumar A; Sarin SK
Gut; 2010 Jun; 59(6):729-35. PubMed ID: 20551457
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices.
Kim HY; So YH; Kim W; Ahn DW; Jung YJ; Woo H; Kim D; Kim MY; Baik SK
J Hepatol; 2019 Mar; 70(3):412-422. PubMed ID: 30389550
[TBL] [Abstract][Full Text] [Related]
16. Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.
Reiberger T; Ferlitsch A; Payer BA; Pinter M; Homoncik M; Peck-Radosavljevic M;
J Gastroenterol; 2012 May; 47(5):561-8. PubMed ID: 22170417
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
[TBL] [Abstract][Full Text] [Related]
18. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R;
Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
[TBL] [Abstract][Full Text] [Related]
19. Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices.
Sharma P; Kumar A; Sharma BC; Sarin SK
Aliment Pharmacol Ther; 2009 Jul; 30(1):48-60. PubMed ID: 19392862
[TBL] [Abstract][Full Text] [Related]
20. Comparison of carvedilol and propranolol for primary prophylaxis of esophageal variceal bleed in cirrhotic patients.
Muhammad Farooq Hanif -; Raja Omer Fiaz -; Muhammad Adnan Iqbal -; Aneeza Ilyas -; Maria -; Khalid Mahmud Khan -; Nooman Gilani -
Pak J Pharm Sci; 2023 May; 36(3):857-862. PubMed ID: 37580935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]